MTOR and glioma: The elevated 2-HG and proliferation levels were significantly reduced (near to 75% and 80%, respectively) after 48-h mTOR inhibitor treatment which confirmed our findings about the 2-HG reducing effect of rapamycin treatment in other 2-HG producing tumour type, in glioma cells.